Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 201
Filtrar
Más filtros

Banco de datos
Tipo del documento
Intervalo de año de publicación
1.
J Med Internet Res ; 22(11): e24018, 2020 11 06.
Artículo en Inglés | MEDLINE | ID: mdl-33027032

RESUMEN

BACKGROUND: COVID-19 has infected millions of people worldwide and is responsible for several hundred thousand fatalities. The COVID-19 pandemic has necessitated thoughtful resource allocation and early identification of high-risk patients. However, effective methods to meet these needs are lacking. OBJECTIVE: The aims of this study were to analyze the electronic health records (EHRs) of patients who tested positive for COVID-19 and were admitted to hospitals in the Mount Sinai Health System in New York City; to develop machine learning models for making predictions about the hospital course of the patients over clinically meaningful time horizons based on patient characteristics at admission; and to assess the performance of these models at multiple hospitals and time points. METHODS: We used Extreme Gradient Boosting (XGBoost) and baseline comparator models to predict in-hospital mortality and critical events at time windows of 3, 5, 7, and 10 days from admission. Our study population included harmonized EHR data from five hospitals in New York City for 4098 COVID-19-positive patients admitted from March 15 to May 22, 2020. The models were first trained on patients from a single hospital (n=1514) before or on May 1, externally validated on patients from four other hospitals (n=2201) before or on May 1, and prospectively validated on all patients after May 1 (n=383). Finally, we established model interpretability to identify and rank variables that drive model predictions. RESULTS: Upon cross-validation, the XGBoost classifier outperformed baseline models, with an area under the receiver operating characteristic curve (AUC-ROC) for mortality of 0.89 at 3 days, 0.85 at 5 and 7 days, and 0.84 at 10 days. XGBoost also performed well for critical event prediction, with an AUC-ROC of 0.80 at 3 days, 0.79 at 5 days, 0.80 at 7 days, and 0.81 at 10 days. In external validation, XGBoost achieved an AUC-ROC of 0.88 at 3 days, 0.86 at 5 days, 0.86 at 7 days, and 0.84 at 10 days for mortality prediction. Similarly, the unimputed XGBoost model achieved an AUC-ROC of 0.78 at 3 days, 0.79 at 5 days, 0.80 at 7 days, and 0.81 at 10 days. Trends in performance on prospective validation sets were similar. At 7 days, acute kidney injury on admission, elevated LDH, tachypnea, and hyperglycemia were the strongest drivers of critical event prediction, while higher age, anion gap, and C-reactive protein were the strongest drivers of mortality prediction. CONCLUSIONS: We externally and prospectively trained and validated machine learning models for mortality and critical events for patients with COVID-19 at different time horizons. These models identified at-risk patients and uncovered underlying relationships that predicted outcomes.


Asunto(s)
Infecciones por Coronavirus/diagnóstico , Infecciones por Coronavirus/mortalidad , Aprendizaje Automático/normas , Neumonía Viral/diagnóstico , Neumonía Viral/mortalidad , Lesión Renal Aguda/epidemiología , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Betacoronavirus , COVID-19 , Estudios de Cohortes , Registros Electrónicos de Salud , Femenino , Mortalidad Hospitalaria , Hospitalización/estadística & datos numéricos , Hospitales , Humanos , Masculino , Persona de Mediana Edad , Ciudad de Nueva York/epidemiología , Pandemias , Pronóstico , Curva ROC , Medición de Riesgo/métodos , Medición de Riesgo/normas , SARS-CoV-2 , Adulto Joven
2.
Clin Oral Implants Res ; 30(4): 306-314, 2019 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-30768875

RESUMEN

OBJECTIVES: We assessed peri-implantitis prevalence, incidence rate, and associated risk factors by analyzing electronic oral health records (EHRs) in an educational institution. METHODS: We used a validated reference cohort comprising all patients receiving dental implants over a 3.5-year period (2,127 patients and 6,129 implants). Electronic oral health records of a random 10% subset were examined for an additional follow-up of ≥2.5 years to assess the presence of radiographic bone loss, defined as >2 mm longitudinal increase in the distance between the implant shoulder and the supporting peri-implant bone level (PBL) between time of placement and follow-up. "Intact" implants had no or ≤2 mm PBL increase from baseline. Electronic oral health record notes were reviewed to corroborate a definitive peri-implantitis diagnosis at implants with progressive bone loss. A nested case-control analysis of peri-implantitis-affected implants randomly matched by age with "intact" implants from peri-implantitis-free individuals identified putative risk factors. RESULTS: The prevalence of peri-implantitis over an average follow-up of 2 years was 34% on the patient level and 21% on the implant level. Corresponding incidence rates were 0.16 and 0.10 per patient-year and implant-year, respectively. Multiple conditional logistic regression identified ill-fitting fixed prosthesis (OR = 5.9; 95% CI: 1.6-21.1), cement-retained prosthesis (OR = 4.5; 2.1-9.5), and radiographic evidence of periodontitis (OR = 3.6; 1.7-7.6) as statistically associated with peri-implantitis. Implant location in the mandible (OR = 0.02; 0.003-0.2) and use of antibiotics in conjunction with implant surgery (OR = 0.19; 0.05-0.7) emerged as protective exposures. CONCLUSIONS: Approximately 1/3 of the patients and 1/5 of all implants experienced peri-implantitis. Ill-fitting/ill-designed fixed and cement-retained restorations, and history of periodontitis emerged as the principal risk factors for peri-implantitis.


Asunto(s)
Implantes Dentales , Periimplantitis , Registros Electrónicos de Salud , Humanos , Incidencia , Prevalencia , Factores de Riesgo , Facultades de Odontología
3.
J Med Internet Res ; 21(1): e11297, 2019 01 30.
Artículo en Inglés | MEDLINE | ID: mdl-30698526

RESUMEN

BACKGROUND: Addiction is one of the most rapidly growing epidemics that currently plagues nations around the world. In the United States, it has cost the government more than US $700 billion a year in terms of health care and other associated costs and is also associated with serious social, physical, and mental consequences. Increasing efforts have been made to tackle this issue at different levels, from primary prevention to rehabilitation across the globe. With the use of digital technology rapidly increasing, an effort to leverage the consumer health information technologies (CHITs) to combat the rising substance abuse epidemic has been underway. CHITs are identified as patient-focused technological platforms aimed to improve patient engagement in health care and aid them in navigating the complex health care system. OBJECTIVE: This review aimed to provide a holistic and overarching view of the breadth of research on primary prevention of substance abuse using CHIT conducted over nearly past five decades. It also aimed to map out the changing landscape of CHIT over this period. METHODS: We conducted a scoping review using the Arksey and O'Malley's modified methodological framework. We searched 4 electronic databases (PubMed, Cochrane, Scopus, and EMBASE). Papers were included if the studies addressed the use of CHIT for primary prevention of substance abuse and were published in English between 1809 and 2018. Studies that did not focus solely on primary prevention or assessed additional comorbid conditions were eliminated. RESULTS: Forty-two papers that met our inclusion criteria were included in the review. These studies were published between 1970 and 2018 and were not restricted by geography, age, race, or sex. The review mapped studies using the most commonly used CHIT platforms for substance abuse prevention from mass media in the 1970s to mobile and social media in 2018. Moreover, 191 studies that were exclusively focused on alcohol prevention were excluded and will be addressed in a separate paper. The studies included had diverse research designs although the majority were randomized controlled trials (RCT) or review papers. Many of the RCTs used interventions based on different behavioral theories such as family interactions, social cognitive theories, and harm-minimization framework. CONCLUSIONS: This review found CHIT platforms to be efficacious and cost-effective in the real-world settings. We also observed a gradual shift in the types and use of CHIT platforms over the past few decades and mapped out their progression. In addition, the review detected a shift in consumer preferences and behaviors from face-to-face interactions to technology-based platforms. However, the studies included in this review only focused on the aspect of primary prevention. Future reviews could assess the effectiveness of platforms for secondary prevention and for prevention of substance abuse among comorbid populations.


Asunto(s)
Información de Salud al Consumidor/métodos , Trastornos Relacionados con Sustancias/prevención & control , Humanos
4.
J Med Syst ; 40(4): 77, 2016 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-26791993

RESUMEN

Recent studies demonstrated that blood pressure (BP) can be estimated using pulse transit time (PTT). For PTT calculation, photoplethysmogram (PPG) is usually used to detect a time lag in pulse wave propagation which is correlated with BP. Until now, PTT and PPG were registered using a set of body-worn sensors. In this study a new methodology is introduced allowing contactless registration of PTT and PPG using high speed camera resulting in corresponding image-based PTT (iPTT) and image-based PPG (iPPG) generation. The iPTT value can be potentially utilized for blood pressure estimation however extent of correlation between iPTT and BP is unknown. The goal of this preliminary feasibility study was to introduce the methodology for contactless generation of iPPG and iPTT and to make initial estimation of the extent of correlation between iPTT and BP "in vivo." A short cycling exercise was used to generate BP changes in healthy adult volunteers in three consecutive visits. BP was measured by a verified BP monitor simultaneously with iPTT registration at three exercise points: rest, exercise peak, and recovery. iPPG was simultaneously registered at two body locations during the exercise using high speed camera at 420 frames per second. iPTT was calculated as a time lag between pulse waves obtained as two iPPG's registered from simultaneous recoding of head and palm areas. The average inter-person correlation between PTT and iPTT was 0.85 ± 0.08. The range of inter-person correlations between PTT and iPTT was from 0.70 to 0.95 (p < 0.05). The average inter-person coefficient of correlation between SBP and iPTT was -0.80 ± 0.12. The range of correlations between systolic BP and iPTT was from 0.632 to 0.960 with p < 0.05 for most of the participants. Preliminary data indicated that a high speed camera can be potentially utilized for unobtrusive contactless monitoring of abrupt blood pressure changes in a variety of settings. The initial prototype system was able to successfully generate approximation of pulse transit time and showed high intra-individual correlation between iPTT and BP. Further investigation of the proposed approach is warranted.


Asunto(s)
Determinación de la Presión Sanguínea/instrumentación , Determinación de la Presión Sanguínea/métodos , Piel , Grabación de Cinta de Video/instrumentación , Adulto , Prueba de Esfuerzo , Estudios de Factibilidad , Femenino , Frecuencia Cardíaca , Humanos , Masculino , Persona de Mediana Edad , Fotopletismografía , Análisis de la Onda del Pulso/instrumentación , Análisis de la Onda del Pulso/métodos
5.
Stud Health Technol Inform ; 310: 961-965, 2024 Jan 25.
Artículo en Inglés | MEDLINE | ID: mdl-38269951

RESUMEN

Previous studies demonstrated an association between influenza vaccination and the likelihood of developing Alzheimer's disease. This study was aimed at assessing whether pneumococcal vaccinations are associated with a lower risk of Alzheimer's disease based on analysis of data from the IBM® MarketScan® Database. Vaccinated and unvaccinated matched cohorts were generated using propensity-score matching with the greedy nearest-neighbor matching algorithm. The conditional logistic regression method was used to estimate the relationship between pneumococcal vaccination and the onset of Alzheimer's disease. There were 142,874 subjects who received the pneumococcal vaccine and 14,392 subjects who did not. The conditional logistic regression indicated that the people who received the pneumococcal vaccine had a significantly lower risk of developing Alzheimer's disease as compared to the people who did not receive any pneumococcal vaccine (OR=0.37; 95%CI: 0.33-0.42; P-value < .0001). Our findings demonstrated that the pneumococcal vaccine was associated with a 63% reduction in the risk of Alzheimer's disease among US adults aged 65 and older.


Asunto(s)
Enfermedad de Alzheimer , Adulto , Humanos , Enfermedad de Alzheimer/epidemiología , Enfermedad de Alzheimer/prevención & control , Vacunación , Inmunización , Vacunas Neumococicas/uso terapéutico , Puntaje de Propensión
6.
Stud Health Technol Inform ; 310: 956-960, 2024 Jan 25.
Artículo en Inglés | MEDLINE | ID: mdl-38269950

RESUMEN

Multiple myeloma (MM) is one of the most common hematological malignancies. The goal of this study was to analyze the sociodemographic, economic, and genetic characteristics of long-term and short-term survival of multiple myeloma patients using EHR data from an academic medical center in New York City. The de-identified analytical dataset comprised 2,111 patients with MM who were stratified based on the length of survival into two groups. Demographic variables, cancer stage, income level, and genetic mutations were analyzed using descriptive statistics and logistic regression. Age, race, and cancer stage were all significant factors that affected the length of survival of multiple myeloma patients. In contrast, gender and income level were not significant factors based on the multivariate adjusted analysis. Older adults, African American patients, and patients who were diagnosed with stage III of multiple myeloma were the people most likely to exhibit short-term survival after the MM diagnosis.


Asunto(s)
Disparidades en el Estado de Salud , Mieloma Múltiple , Anciano , Humanos , Centros Médicos Académicos , Negro o Afroamericano , Registros Electrónicos de Salud , Mieloma Múltiple/mortalidad , Mutación , Tasa de Supervivencia
7.
Stud Health Technol Inform ; 310: 1569-1573, 2024 Mar 01.
Artículo en Inglés | MEDLINE | ID: mdl-38426878

RESUMEN

Successful implementation of telehealth platforms requires a detailed understanding of patient's needs, preferences, and attitudes toward a home-based platform. The goal of this study was to identify patient-centered characteristics of a cancer rehabilitation system based on cognitive evaluation of user interface and semi-structured qualitative interviews. Quantitative and qualitative feedback from 29 patients with metastatic urogenital cancer was collected after using a cancer telerehabilitation system. Heuristic evaluation, cognitive walkthrough, and analysis of qualitative interviews demonstrated a high level of support for the concept of home-based cancer telerehabilitation by cancer patients. Post-task surveys demonstrated sufficient usability and satisfaction scores from the participants. The patients provided valuable and insightful comments on how to further improve the functionality and interface of the platform. Further improvement of the system usability, consistency, and accessibility based on the patient-centered design principles will significantly facilitate the implementation of cancer telerehabilitation in clinical practice.


Asunto(s)
Neoplasias , Telemedicina , Telerrehabilitación , Humanos , Terapia por Ejercicio , Atención Dirigida al Paciente
8.
AMIA Jt Summits Transl Sci Proc ; 2024: 419-428, 2024.
Artículo en Inglés | MEDLINE | ID: mdl-38827087

RESUMEN

Using physiological data from wearable devices, the study aimed to predict exercise exertion levels by building deep learning classification and regression models. Physiological data were obtained using an unobtrusive chest-worn ECG sensor and portable pulse oximeter from healthy individuals who performed 16-minute cycling exercise sessions. During each session, real-time ECG, pulse rate, oxygen saturation, and revolutions per minute (RPM) data were collected at three intensity levels. Subjects' ratings of perceived exertion (RPE) were collected once per minute. Each 16-minute exercise session was divided into eight 2-minute windows. The self-reported RPEs, heart rate, RPMs, and oxygen saturation levels were averaged for each window to form the predictive features. In addition, heart rate variability (HRV) features were extracted from the ECG for each window. Different feature selection algorithms were used to choose top-ranked predictors. The best predictors were then used to train and test deep learning models for regression and classification analysis. Our results showed the highest accuracy and F1 score of 98.2% and 98%, respectively in training the models. For testing the models, the highest accuracy and F1 score were 80%.

9.
Stud Health Technol Inform ; 310: 589-593, 2024 Jan 25.
Artículo en Inglés | MEDLINE | ID: mdl-38269877

RESUMEN

Chronic Obstructive Pulmonary Disease (COPD) frequently coincides with other comorbidities such as congestive heart failure, hypertension, coronary artery disease, or atrial fibrillation. The exhibition of overlapping sets of symptoms associated with these conditions prevents early identification of an acute exacerbation upon admission to a hospital. Early identification of the underlying cause of exacerbation allows timely prescription of an optimal treatment plan as well as allows avoiding unnecessary clinical tests and specialist consultations. The aim of this study was to develop a predictive model for early identification of COPD exacerbation by using the clinical notes generated within 24 hours of admission to the hospital. The study cohort included patients with a prior diagnosis of COPD. Four predictive models have been developed, among which the support vector machine showed the best performance based on the resulting 80% F1 score.


Asunto(s)
Fibrilación Atrial , Enfermedad de la Arteria Coronaria , Insuficiencia Cardíaca , Enfermedad Pulmonar Obstructiva Crónica , Humanos , Diagnóstico Diferencial , Enfermedad Pulmonar Obstructiva Crónica/diagnóstico
10.
AMIA Jt Summits Transl Sci Proc ; 2024: 172-181, 2024.
Artículo en Inglés | MEDLINE | ID: mdl-38827066

RESUMEN

Chronic obstructive pulmonary disease (COPD) is a global health issue causing significant illness and death. Pulmonary Rehabilitation (PR) offers non-pharmacological treatment, including education, exercise, and psychological support which was shown to improve clinical outcomes. In both stable COPD and after an acute exacerbation, PR has been demonstrated to increase exercise capacity, decrease dyspnea, and enhance quality of life. Despite these benefits, referrals for PR for COPD treatment remain low. This study aims to evaluate the perceptions of healthcare providers for referring a COPD patient to PR. Semi-structured qualitative interviews were conducted with pulmonary specialists, hospitalists, and emergency department physicians. Domains and constructs from the Consolidated Framework for Implementation Research (CFIR) were applied to the qualitative data to organize, analyze, and identify the barriers and facilitators to referring COPD patients. The findings from this study will help guide strategies to improve the referral process for PR.

11.
JMIR Med Inform ; 12: e56243, 2024 Aug 19.
Artículo en Inglés | MEDLINE | ID: mdl-39037700

RESUMEN

BACKGROUND: Understanding the multifaceted nature of health outcomes requires a comprehensive examination of the social, economic, and environmental determinants that shape individual well-being. Among these determinants, behavioral factors play a crucial role, particularly the consumption patterns of psychoactive substances, which have important implications on public health. The Global Burden of Disease Study shows a growing impact in disability-adjusted life years due to substance use. The successful identification of patients' substance use information equips clinical care teams to address substance-related issues more effectively, enabling targeted support and ultimately improving patient outcomes. OBJECTIVE: Traditional natural language processing methods face limitations in accurately parsing diverse clinical language associated with substance use. Large language models offer promise in overcoming these challenges by adapting to diverse language patterns. This study investigates the application of the generative pretrained transformer (GPT) model in specific GPT-3.5 for extracting tobacco, alcohol, and substance use information from patient discharge summaries in zero-shot and few-shot learning settings. This study contributes to the evolving landscape of health care informatics by showcasing the potential of advanced language models in extracting nuanced information critical for enhancing patient care. METHODS: The main data source for analysis in this paper is Medical Information Mart for Intensive Care III data set. Among all notes in this data set, we focused on discharge summaries. Prompt engineering was undertaken, involving an iterative exploration of diverse prompts. Leveraging carefully curated examples and refined prompts, we investigate the model's proficiency through zero-shot as well as few-shot prompting strategies. RESULTS: Results show GPT's varying effectiveness in identifying mentions of tobacco, alcohol, and substance use across learning scenarios. Zero-shot learning showed high accuracy in identifying substance use, whereas few-shot learning reduced accuracy but improved in identifying substance use status, enhancing recall and F1-score at the expense of lower precision. CONCLUSIONS: Excellence of zero-shot learning in precisely extracting text span mentioning substance use demonstrates its effectiveness in situations in which comprehensive recall is important. Conversely, few-shot learning offers advantages when accurately determining the status of substance use is the primary focus, even if it involves a trade-off in precision. The results contribute to enhancement of early detection and intervention strategies, tailor treatment plans with greater precision, and ultimately, contribute to a holistic understanding of patient health profiles. By integrating these artificial intelligence-driven methods into electronic health record systems, clinicians can gain immediate, comprehensive insights into substance use that results in shaping interventions that are not only timely but also more personalized and effective.

12.
AMIA Jt Summits Transl Sci Proc ; 2024: 155-161, 2024.
Artículo en Inglés | MEDLINE | ID: mdl-38827093

RESUMEN

The goal of this study was to analyze diagnostic discrepancies between emergency department (ED) and hospital discharge diagnoses in patients with congestive heart failure admitted to the ED. Using a synthetic dataset from the Department of Veterans Affairs, the patients' primary diagnoses were compared at two levels: diagnostic category and body system. With 12,621 patients and 24,235 admission cases, the study found a 58% mismatch rate at the category level, which was reduced to 30% at the body system level. Diagnostic categories associated with higher levels of mismatch included aplastic anemia, pneumonia, and bacterial infections. In contrast, diagnostic categories associated with lower levels of mismatch included alcohol-related disorders, COVID-19, cardiac dysrhythmias, and gastrointestinal hemorrhage. Further investigation revealed that diagnostic mismatches are associated with longer hospital stays and higher mortality rates. These findings highlight the importance of reducing diagnostic uncertainty, particularly in specific diagnostic categories and body systems, to improve patient care following ED admission.

13.
Stud Health Technol Inform ; 310: 1434-1435, 2024 Jan 25.
Artículo en Inglés | MEDLINE | ID: mdl-38269683

RESUMEN

The study was aimed at exploring patients' experiences after the completion of a 12-month pulmonary telerehabilitation (PR) program. Semi-structured qualitative interviews were conducted with 16 COPD patients. The interviews were analyzed using a thematic approach to identify patterns and themes. The patients exhibited high acceptability and satisfaction with the remote PR program and provided valuable input for its improvement. These insights will be used for the implementation of a patient-centered COPD telerehabilitation system.


Asunto(s)
Enfermedad Pulmonar Obstructiva Crónica , Telerrehabilitación , Humanos , Pacientes
14.
JMIR Cancer ; 10: e56969, 2024 Aug 21.
Artículo en Inglés | MEDLINE | ID: mdl-39079103

RESUMEN

BACKGROUND: Cancer is a significant public health issue worldwide. Treatments such as surgery, chemotherapy, and radiation therapy often cause psychological and physiological side effects, affecting patients' ability to function and their quality of life (QoL). Physical activity is crucial to cancer rehabilitation, improving physical function and QoL and reducing cancer-related fatigue. However, many patients face barriers to accessing cancer rehabilitation due to socioeconomic factors, transportation issues, and time constraints. Telerehabilitation can potentially overcome these barriers by delivering rehabilitation remotely. OBJECTIVE: The aim of the study is to identify how telemedicine is used for the rehabilitation of patients with cancer. METHODS: This scoping review followed recognized frameworks. We conducted an electronic literature search on PubMed for studies published between January 2015 and May 2023. Inclusion criteria were studies reporting physical therapy telerehabilitation interventions for patients with cancer, including randomized and nonrandomized controlled trials, feasibility studies, and usability studies. In total, 21 studies met the criteria and were included in the final review. RESULTS: Our search yielded 37 papers, with 21 included in the final review. Randomized controlled trials comprised 47% (n=10) of the studies, with feasibility studies at 33% (n=7) and usability studies at 19% (n=4). Sample sizes were typically 50 or fewer participants in 57% (n=12) of the reports. Participants were generally aged 65 years or younger (n=17, 81%), with a balanced gender distribution. Organ-specific cancers were the focus of 66% (n=14) of the papers, while 28% (n=6) included patients who were in the posttreatment period. Web-based systems were the most used technology (n=13, 61%), followed by phone call or SMS text messaging-based systems (n=9, 42%) and mobile apps (n=5, 23%). Exercise programs were mainly home based (n=19, 90%) and included aerobic (n=19, 90%), resistance (n=13, 61%), and flexibility training (n=7, 33%). Outcomes included improvements in functional capacity, cognitive functioning, and QoL (n=10, 47%); reductions in pain and hospital length of stay; and enhancements in fatigue, physical and emotional well-being, and anxiety. Positive effects on feasibility (n=3, 14%), acceptability (n=8, 38%), and cost-effectiveness (n=2, 9%) were also noted. Functional outcomes were frequently assessed (n=19, 71%) with tools like the 6-minute walk test and grip strength tests. CONCLUSIONS: Telerehabilitation for patients with cancer is beneficial and feasible, with diverse approaches in study design, technologies, exercises, and outcomes. Future research should focus on developing standardized methodologies, incorporating objective measures, and exploring emerging technologies like virtual reality, wearable or noncontact sensors, and artificial intelligence to optimize telerehabilitation interventions. Addressing these areas can enhance clinical practice and improve outcomes for remote rehabilitation with patients.

15.
JMIR Ment Health ; 11: e56056, 2024 Apr 25.
Artículo en Inglés | MEDLINE | ID: mdl-38663004

RESUMEN

BACKGROUND: Depression significantly impacts quality of life, affecting approximately 280 million people worldwide. However, only 16.5% of those affected receive treatment, indicating a substantial treatment gap. Immersive technologies (IMTs) such as virtual reality (VR) and augmented reality offer new avenues for treating depression by creating immersive environments for therapeutic interventions. Despite their potential, significant gaps exist in the current evidence regarding the design, implementation, and use of IMTs for depression care. OBJECTIVE: We aim to map the available evidence on IMT interventions targeting depression treatment. METHODS: This scoping review followed a methodological framework, and we systematically searched databases for studies on IMTs and depression. The focus was on randomized clinical trials involving adults and using IMTs. The selection and charting process involved multiple reviewers to minimize bias. RESULTS: The search identified 16 peer-reviewed articles, predominantly from Europe (n=10, 63%), with a notable emphasis on Poland (n=9, 56%), which contributed to more than half of the articles. Most of the studies (9/16, 56%) were conducted between 2020 and 2021. Regarding participant demographics, of the 16 articles, 5 (31%) exclusively involved female participants, and 7 (44%) featured participants whose mean or median age was >60 years. Regarding technical aspects, all studies focused on VR, with most using stand-alone VR headsets (14/16, 88%), and interventions typically ranging from 2 to 8 weeks, predominantly in hospital settings (11/16, 69%). Only 2 (13%) of the 16 studies mentioned using a specific VR design framework in planning their interventions. The most frequently used therapeutic approach was Ericksonian psychotherapy, used in 56% (9/16) of the studies. Notably, none of the articles reported using an implementation framework or identified barriers and enablers to implementation. CONCLUSIONS: This scoping review highlights the growing interest in using IMTs, particularly VR, for depression treatment but emphasizes the need for more inclusive and comprehensive research. Future studies should explore varied therapeutic approaches and cost-effectiveness as well as the inclusion of augmented reality to fully realize the potential of IMTs in mental health care.


Asunto(s)
Depresión , Humanos , Depresión/terapia , Terapia de Exposición Mediante Realidad Virtual/métodos
16.
JMIR Serious Games ; 12: e62842, 2024 Aug 09.
Artículo en Inglés | MEDLINE | ID: mdl-39046869

RESUMEN

BACKGROUND: Immersive virtual reality (VR) is a promising therapy to improve the experience of patients with critical illness and may help avoid postdischarge functional impairments. However, the determinants of interest and usability may vary locally and reports of uptake in the literature are variable. OBJECTIVE: The aim of this mixed methods feasibility study was to assess the acceptability and potential utility of immersive VR in critically ill patients at a single institution. METHODS: Adults without delirium who were admitted to 1 of 2 intensive care units were offered the opportunity to participate in 5-15 minutes of immersive VR delivered by a VR headset. Patient vital signs, heart rate variability, mood, and pain were assessed before and after the VR experience. Pre-post comparisons were performed using paired 2-sided t tests. A semistructured interview was administered after the VR experience. Patient descriptions of the experience, issues, and potential uses were summarized with thematic analysis. RESULTS: Of the 35 patients offered the chance to participate, 20 (57%) agreed to partake in the immersive VR experience, with no difference in participation rate by age. Improvements were observed in overall mood (mean difference 1.8 points, 95% CI 0.6-3.0; P=.002), anxiety (difference of 1.7 points, 95% CI 0.8-2.7; P=.001), and pain (difference of 1.3 points, 95% CI 0.5-2.1; P=.003) assessed on 1-10 scales. The heart rate changed by a mean of -1.1 (95% CI -0.3 to -1.9; P=.008) beats per minute (bpm) from a baseline of 86.1 (SD 11.8) bpm and heart rate variability, assessed by the stress index (SI), changed by a mean of -5.0 (95% CI -1.5 to -8.5; P=.004) seconds-2 from a baseline SI of 40.0 (SD 23) seconds-2. Patients commented on the potential for the therapy to address pain, lessen anxiety, and facilitate calmness. Technical challenges were minimal and there were no adverse effects observed. CONCLUSIONS: Patient acceptance of immersive VR was high in a mostly medical intensive care population with little prior VR experience. Patients commented on the potential of immersive VR to ameliorate cognitive and emotional symptoms. Investigators can consider integrating minimally modified commercial VR headsets into the existing intensive care unit workflow to further assess VR's efficacy for a variety of endpoints.

17.
Stud Health Technol Inform ; 310: 1428-1429, 2024 Jan 25.
Artículo en Inglés | MEDLINE | ID: mdl-38269680

RESUMEN

This research aimed to develop a model for real-time prediction of aerobic exercise exertion levels. ECG signals were registered during 16-minute cycling exercises. Perceived ratings of exertion (RPE) were collected each minute from the study participants. Based on the reported RPE, each consecutive minute of the exercise was assigned to the "high exertion" or "low exertion" class. The characteristics of heart rate variability (HRV) in time and frequency domains were used as predictive features. The top ten ranked predictive features were selected using the minimum redundancy maximum relevance (mRMR) algorithm. The support vector machine demonstrated the highest accuracy with an F1 score of 82%.


Asunto(s)
Esfuerzo Físico , Dispositivos Electrónicos Vestibles , Humanos , Ejercicio Físico , Terapia por Ejercicio , Aprendizaje Automático
18.
JMIR Ment Health ; 11: e59560, 2024 Aug 21.
Artículo en Inglés | MEDLINE | ID: mdl-39167795

RESUMEN

BACKGROUND: The introduction of natural language processing (NLP) technologies has significantly enhanced the potential of self-administered interventions for treating anxiety and depression by improving human-computer interactions. Although these advances, particularly in complex models such as generative artificial intelligence (AI), are highly promising, robust evidence validating the effectiveness of the interventions remains sparse. OBJECTIVE: The aim of this study was to determine whether self-administered interventions based on NLP models can reduce depressive and anxiety symptoms. METHODS: We conducted a systematic review and meta-analysis. We searched Web of Science, Scopus, MEDLINE, PsycINFO, IEEE Xplore, Embase, and Cochrane Library from inception to November 3, 2023. We included studies with participants of any age diagnosed with depression or anxiety through professional consultation or validated psychometric instruments. Interventions had to be self-administered and based on NLP models, with passive or active comparators. Outcomes measured included depressive and anxiety symptom scores. We included randomized controlled trials and quasi-experimental studies but excluded narrative, systematic, and scoping reviews. Data extraction was performed independently by pairs of authors using a predefined form. Meta-analysis was conducted using standardized mean differences (SMDs) and random effects models to account for heterogeneity. RESULTS: In all, 21 articles were selected for review, of which 76% (16/21) were included in the meta-analysis for each outcome. Most of the studies (16/21, 76%) were recent (2020-2023), with interventions being mostly AI-based NLP models (11/21, 52%); most (19/21, 90%) delivered some form of therapy (primarily cognitive behavioral therapy: 16/19, 84%). The overall meta-analysis showed that self-administered interventions based on NLP models were significantly more effective in reducing both depressive (SMD 0.819, 95% CI 0.389-1.250; P<.001) and anxiety (SMD 0.272, 95% CI 0.116-0.428; P=.001) symptoms compared to various control conditions. Subgroup analysis indicated that AI-based NLP models were effective in reducing depressive symptoms (SMD 0.821, 95% CI 0.207-1.436; P<.001) compared to pooled control conditions. Rule-based NLP models showed effectiveness in reducing both depressive (SMD 0.854, 95% CI 0.172-1.537; P=.01) and anxiety (SMD 0.347, 95% CI 0.116-0.578; P=.003) symptoms. The meta-regression showed no significant association between participants' mean age and treatment outcomes (all P>.05). Although the findings were positive, the overall certainty of evidence was very low, mainly due to a high risk of bias, heterogeneity, and potential publication bias. CONCLUSIONS: Our findings support the effectiveness of self-administered NLP-based interventions in alleviating depressive and anxiety symptoms, highlighting their potential to increase accessibility to, and reduce costs in, mental health care. Although the results were encouraging, the certainty of evidence was low, underscoring the need for further high-quality randomized controlled trials and studies examining implementation and usability. These interventions could become valuable components of public health strategies to address mental health issues. TRIAL REGISTRATION: PROSPERO International Prospective Register of Systematic Reviews CRD42023472120; https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42023472120.


Asunto(s)
Ansiedad , Depresión , Procesamiento de Lenguaje Natural , Humanos , Depresión/terapia , Depresión/prevención & control , Ansiedad/terapia , Ansiedad/prevención & control , Autocuidado/métodos
19.
Stud Health Technol Inform ; 305: 303-306, 2023 Jun 29.
Artículo en Inglés | MEDLINE | ID: mdl-37387023

RESUMEN

The use of hydroxychloroquine (HCQ) in the prevention or treatment of COVID-19 remains controversial due to the insufficient supporting evidence and clinical studies indicating that it does not reduce COVID-19 mortality. Its potential protective effects against SARS-CoV-2 are still unclear. Big data resources, such as MarketScan database containing over 30 million insured participants annually, have not been used systematically to assess the association between long-term HCQ use and the risk of COVID-19. This retrospective study aimed to determine the protective effect of HCQ using the MarketScan database. We examined COVID-19 incidence from January to September 2020 among adult patients with systemic lupus erythematosus or rheumatoid arthritis who had received HCQ for at least 10 months in 2019 compared to those who did not. Propensity score matching was used to control for confounding variables and make the HCQ and non-HCQ groups comparable in this study. After matching at the ratio of 1:2, the analytical dataset comprised 13,932 patients who received HCQ for over 10 months and 27,754 HCQ-naïve patients. Multivariate logistic regression showed that long-term HCQ use was associated with a lower likelihood of COVID-19 in patients who had been receiving HCQ for over 10 months (OR=0.78, 95% CI: 0.69-0.88). These findings suggest that long-term HCQ use may provide protection against COVID-19.


Asunto(s)
COVID-19 , Hidroxicloroquina , Adulto , Humanos , Hidroxicloroquina/efectos adversos , COVID-19/prevención & control , Estudios Retrospectivos , SARS-CoV-2 , Tratamiento Farmacológico de COVID-19 , Puntaje de Propensión
20.
Stud Health Technol Inform ; 302: 866-870, 2023 May 18.
Artículo en Inglés | MEDLINE | ID: mdl-37203519

RESUMEN

Alzheimer's disease is a chronic neurodegenerative disease with multiple pathogenesis pathways. Sildenafil, one of the phosphodiesterase-5 inhibitors, was proven to have effective benefits in transgenic Alzheimer's disease mice. The purpose of the study was to investigate the relationship between sildenafil use and the risk of Alzheimer's disease based on the IBM® MarketScan® Database covering over 30 million employees and family members per year. Sildenafil and non-sildenafil-matched cohorts were generated using propensity-score matching with the greedy nearest-neighbor algorithm. The propensity score stratified univariate analysis and the Cox regression model showed that sildenafil use was significantly associated with a 60% risk reduction of developing Alzheimer's disease (HR=0.40; 95%CI:0.38-0.44; P<.0001) compared to the cohort of individuals who did not take sildenafil. Sex-stratified analyses revealed that sildenafil was related to a lower risk of Alzheimer's disease in subgroups of both males and females. Our findings demonstrated a significant association between sildenafil use and a lower risk of Alzheimer's disease.


Asunto(s)
Enfermedad de Alzheimer , Enfermedades Neurodegenerativas , Masculino , Ratones , Femenino , Animales , Enfermedad de Alzheimer/inducido químicamente , Enfermedad de Alzheimer/prevención & control , Citrato de Sildenafil/efectos adversos , Macrodatos , Riesgo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA